Publications by authors named "Alison Loren"

Claim this Profile
M
Management of Cancer During Pregnancy: ASCO Guideline.
Alison W Loren, Christina Lacchetti, Frédéric Amant, Elyce H Cardonick, Lisa A Carey

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Pediatric and Adolescent Considerations for the Revised ASCO Guidelines.
H Irene Su, Christina Lacchetti, Alison Loren

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.
Alison W Loren, Marco Mielcarek, Javier Bolaños-Meade, Jonathan Brammer, Meredith Cowden

J Natl Compr Canc Netw· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, Janelle Olson, Jianqun Kou, Alison Loren

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Fertility Preservation in People With Cancer: ASCO Guideline Update.
H Irene Su, Christina Lacchetti, Joseph Letourneau, Ann H Partridge, Rubina Qamar, Alison W Loren

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Art of the Art of Oncology.
Mikkael A Sekeres, Gregory A Abel, Timothy Gilligan, Stephanie L Graff, Gregory P Kalemkerian, Alison W Loren

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period.
Heather Lazarow, Alison Carulli, Tara McWilliams, Colleen Kucharczuk, Lauren Hollander, Alison Loren

Support Care Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.
Sameem Abedin, Michael J Martens, Javier Bolaños-Meade, Monzr M Al Malki, Qinghua Lian, Alison W Loren

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Fertility Preservation in People With Cancer: ASCO Guideline Update.
H Irene Su, Christina Lacchetti, Joseph Letourneau, Ann H Partridge, Rubina Qamar, Alison W Loren

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.
Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey, Alison Loren

Eur J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility Preservation in People With Cancer: ASCO Guideline Update.
H Irene Su, Christina Lacchetti, Joseph Letourneau, Ann H Partridge, Rubina Qamar, Alison W Loren

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility Preservation in People With Cancer: ASCO Guideline Clinical Insights.
Alison W Loren, Christina Lacchetti, H Irene Su

JCO Oncol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease.
Emily Baumrin, Peter F Cronholm, Matthew D Kearney, Mlka Mengesha, Laura G Cesar, Alison W Loren

JAMA Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko, Alison W Loren

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving racial/ethnic disparities in AML survival in the novel therapy era.
Xin Wang, Phyllis A Gimotty, Andrew H Matthews, Ronac Mamtani, Selina M Luger, Alison W Loren

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.
Steven J Siegel, Susan DeWolf, Joseph Schmalz, Wael Saber, Jiayi Dong, Lorenzo Iovino, Lorenzo Cagnin, Alison W Loren

medRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-mediated CAR T therapy resistance in AML.
Anand S Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Patrick W Mellors, Alison W Loren

Nat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease.
Savannah M Alvarado, Olivia G Cohen, Katherine Lattanzio, Paul Haun, Joel M Gelfand, Alison W Loren

Am J Dermatopathol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Alison W Loren

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
Lindsey Chippendale, Craig W Freyer, Alison Carulli, Daria V Babushok, Noelle V Frey, Alison W Loren

J Oncol Pharm Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
Anthony D Sung, Thuy Koll, Shannon H Gier, Alessandro Racioppi, Griffin White, Alison W Loren

Transplant Cell Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Emily Baumrin, Daniel B Shin, Nandita Mitra, Joseph Pidala, Najla El Jurdi, Alison W Loren

JAMA Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies.
Supriya Rastogi, Ellen J Kim, Joel M Gelfand, Alison W Loren, Emily Baumrin

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility Preservation in Adolescents and Young Adults With Cancer: A Case-Based Review.
Karen Burns, Alison W Loren

J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.
Craig W Freyer, Alison Carulli, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Alison W Loren

Leuk Lymphoma· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis